News
Discover the latest news and research updates from the John Curtin School of Medical Research at ANU. Stay informed on medical advancements.
- News
- Research story
- Success story
Kathleen Folbigg was imprisoned over the deaths of her four children. Then, an ANU-led breakthrough uncovered the medical mystery behind the tragedy.
- News
- Success story
Thirteen PhD and 26 Honours students completed their academic research and graduated from JCSMR this December 2023.
- News
- Success story
The ErythroSight team has developed a novel therapeutic and manufacturing pipeline that harnesses red blood cell extracellular vesicles to treat retinal degenerations such as age-related macular degeneration (AMD), one of the leading causes of incurable blindness in the developed world.
- News
- Success story
JCSMR Dr Cynthia Turnbull and the scientists have discovered a previously unknown function of the protein, known as DECTIN-1, which in its mutated state limits the production of T regulatory cells or so-called ‘guardian’ cells in the immune system.
- News
The awe-inspiring story of 9-year-old Zara Skepev, who raised $14,325 for brain cancer research through her creative endeavour of crafting and selling over 300 unique handmade earrings.
- News
- Success story
PhD student Damien Muckle had an amazing time attending some of the biggest Neurobiology of Drosophila Conferences across the world thanks to JCSMR PhD Travel Fund.
- News
- Success story
The University has proudly celebrated the outstanding contributions of its alumni community at the 2023 ANU Alumni Awards.
- News
- Success story
Professor Si Ming Man of the John Curtin School of Medical Research (JCSMR) listed among the world’s most highly cited researchers, placing among the top 1% of researchers worldwide for the third time.
- News
- Success story
JCSMR-led project developed by The Lee Group headed by Dr Woei Ming Steve Lee, was one of the 10 selected medical science projects chosen to bridge the “valley of death” by Australian Economic Accelerator (AEA) scheme.